Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any non-syndromic X-linked intellectual disability in which the cause of the disease is a mutation in the GDI1 gene.
Features include always present findings: Intellectual disability and Severe intellectual disability; and common findings: Mild intellectual disability and Specific learning disability. 7 total HPO annotations.
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 8:51 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 6 | Mild intellectual disability, Generalized non-motor (absence) seizure, Global developmental delay |
Muscles | 1 | Axial hypotonia |
GDI1 encodes GDP dissociation inhibitor 1 (447 aa). Regulates the GDP/GTP exchange reaction of most Rab proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP to them. Highest expression in Brain Cerebellum (591.2 TPM) and Brain Cerebellar Hemisphere (586.3 TPM).
Intellectual disability, X-linked 41 is associated with mutations in the GDI1 gene on chromosome X.
GDI1 is classified as a druggable target with score 13.1.
Genetic testing for GDI1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for intellectual disability, X-linked 41 has been reported in the published literature.
Phenotype severity distribution: 2 always present features, 2 common features.
No clinical trials have been registered for intellectual disability, X-linked 41.
39 publications have been identified in PubMed for intellectual disability, X-linked 41. Research spans Case Report / Case Series (23%), Epidemiology / Natural History (23%), and Basic Science / Preclinical (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 9 | 23% |
Disease patterns and progression | 9 | 23% |
Laboratory research | 7 | 18% |
Testing and diagnosis research | 5 | 13% |
Research summaries | 4 | 10% |
Clinical study results | 3 | 8% |
Other research | 1 | 3% |
New treatment approaches | 1 | 3% |
Duan H (2026). [PMID: 42244324](https://pubmed.ncbi.nlm.nih.gov/42244324/). *Zhong Nan Da Xue Xue Bao Yi Xue Ban*. [Review / Meta-Analysis]
Wright MA (2026). [PMID: 40696909](https://pubmed.ncbi.nlm.nih.gov/40696909/). *Journal of child neurology*. [Review / Meta-Analysis]
Pan X (2026). [PMID: 41764152](https://pubmed.ncbi.nlm.nih.gov/41764152/). *Journal of molecular medicine (Berlin, Germany)*. [Diagnostic / Biomarker]
Zhang S (2026). [PMID: 41478433](https://pubmed.ncbi.nlm.nih.gov/41478433/). *Brain research bulletin*. [Basic Science / Preclinical]
Martinez Diaz D (2026). [PMID: 40971552](https://pubmed.ncbi.nlm.nih.gov/40971552/). *Journal of child neurology*. [Basic Science / Preclinical]
McLennan Y (2026). [PMID: 41351347](https://pubmed.ncbi.nlm.nih.gov/41351347/). *Movement disorders : official journal of the Movement Disorder Society*. [Case Report / Case Series]
Bruschi F (2026). [PMID: 41144879](https://pubmed.ncbi.nlm.nih.gov/41144879/). *Movement disorders : official journal of the Movement Disorder Society*. [Epidemiology / Natural History]
Peters SU (2026). [PMID: 40567120](https://pubmed.ncbi.nlm.nih.gov/40567120/). *J Child Neurol*. [Other]
Lam J (2026). [PMID: 41779991](https://pubmed.ncbi.nlm.nih.gov/41779991/). *Pain Med Case Rep*. [Case Report / Case Series]
Boussetta A (2026). [PMID: 41501258](https://pubmed.ncbi.nlm.nih.gov/41501258/). *Pediatr Nephrol*. [Case Report / Case Series]